AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇼

LENALIDOMIDE in Zimbabwe

12 products registered with MCAZ — 12 active

Brand / ProductReg. No.HolderStatusExpires
LENALIDOMIDE 10MG
CAPSULE; ORAL
2026/9.6/7383GLENMARK PHARMACEUTICAL LIMITEDactive31 Mar 2031
GLENALIDOM 25
CAPSULE; ORAL
2026/9.6/7385GLENMARK PHARMACEUTICAL LIMITEDactive31 Mar 2031
GLENALIDOM 5
CAPSULE; ORAL
2026/9.6/7382GLENMARK PHARMACEUTICAL LIMITEDactive31 Mar 2031
GLENALIDOM 15
CAPSULE; ORAL
2026/9.6/7384GLENMARK PHARMACEUTICAL LIMITEDactive31 Mar 2031
LENOSIDE 25
CAPSULE; ORAL
2020/9.4/6004CIPLA LTDactive18 Jul 2029
LENOSIDE 10
CAPSULE; ORAL
2020/9.4/6002CIPLA LTDactive18 Jul 2029
LENOSIDE 15
CAPSULE; ORAL
2020/9.4/6003CIPLA LTDactive18 Jul 2029
ADDCLENA 5
CAPSULE
2022/9.6/6339MYLAN LABORATORIES LIMITED [OTL]active31 Dec 2027
ADDCLENA 10
CAPSULE
2022/9.6/6340MYLAN LABORATORIES LIMITED [OTL]active31 Dec 2027
MYELOPAST 10
CAPSULE; ORAL
2026/9.6/7292MSN LABORATORIES PRIVATE LIMITEDactive31 Dec 2027
MYELOPAST 25
CAPSULE; ORAL
2026/9.6/7293MSN LABORATORIES PRIVATE LIMITEDactive31 Dec 2027
ADDCLENA 15
CAPSULE
2022/9.6/6341MYLAN LABORATORIES LIMITED [OTL]active31 Dec 2027

LENALIDOMIDE — MCAZ Registration Details

MCAZ (Zimbabwe) has 12 registered products containing LENALIDOMIDE, of which 12 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track LENALIDOMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.